Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Phase 1/2
160
about 7.3 years
18–65
1 site in PA
What this study is about
Researchers are testing whether cromoglicate, a treatment, can help people with schizophrenia. The trial will last 2647 days and involve approximately 160 participants. Participants will be randomly assigned to receive either cromoglicate or a placebo.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Cromoglycate
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Improvement in positive symptoms
Secondary: Cognition, Negative Symptoms, Quality of Life Scale (QOL), Total Symptoms
Psychiatry / Mental Health